Drugs / Lavender
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02670941 | Jan 2016 → Sep 2018 | chemotherapy-induced toxicity | University of Rochester | Terminated | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05251337 | Mar 2022 → Jun 2023 | anxiety, chemotherapy-induced toxicity | Indiana University | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03097484 | Jul 2015 → Apr 2017 | neonatal abstinence syndrome | John M. Daniel | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06100029 | Nov 2023 → Nov 2024 | delirium | Chongqing Traditional Chinese Medicine Hospital | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06114472 Comparator | Oct 2023 → Apr 2024 | — | Assiut University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lavender | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02670941 ↗ |
| Known as | LAV-110 | “The lavender oil (LAV-110) was steam distilled from lavender grown in Kashmir Valley in India.” NCT02670941 ↗ |
| Route | Inhaled | “lavender inhaled aromatherapy patches” NCT05251337 ↗ |